<DOC>
	<DOCNO>NCT00618202</DOCNO>
	<brief_summary>The objective study assess bioequivalence potential generic 750 mg balsalazide disodium capsule formulation compare Salix Pharmaceutical 's 750 mg balsalazide disodium capsule , Colazal , follow single 750 mg dose , administer fasting condition .</brief_summary>
	<brief_title>A Single Dose , 2-Period , 2-Treatment , 2-Way Crossover Bioequivalency Study Balsalazide Disodium 750 mg Capsules Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<mesh_term>Balsalazide</mesh_term>
	<criteria>No clinically significant abnormal finding physical examination , medical history , clinical laboratory result screen . Positive test HIV , Hepatitis B , Hepatitis C. Treatment know enzyme alter drug . History allergic adverse response balsalazide , mesalamine , salicylate , relate drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>